These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 31545110)
1. Prevalence of early discontinuation and associated factors among a retrospective cohort of etonogestrel contraceptive implant users. Peterson AM; Brown A; Savage A; Dempsey A Eur J Contracept Reprod Health Care; 2019 Dec; 24(6):475-479. PubMed ID: 31545110 [No Abstract] [Full Text] [Related]
2. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding. Ireland LD; Goyal V; Raker CA; Murray A; Allen RH Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904 [TBL] [Abstract][Full Text] [Related]
3. Twelve-month discontinuation of etonogestrel implant in an outpatient pediatric setting. Berlan E; Mizraji K; Bonny AE Contraception; 2016 Jul; 94(1):81-6. PubMed ID: 26948183 [TBL] [Abstract][Full Text] [Related]
4. The association between BMI and continuity of etonogestrel (ENG)-releasing implant. Mohr-Sasson A; Dalal L; Bhalwal A Int J Gynaecol Obstet; 2024 Oct; 167(1):254-258. PubMed ID: 38712353 [TBL] [Abstract][Full Text] [Related]
5. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial. Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217 [TBL] [Abstract][Full Text] [Related]
6. Etonogestrel implant as a contraceptive choice; patient acceptability and adverse effect profile in a general practice setting. Riney S; O'Shea B; Forde A Ir Med J; 2009 Jan; 102(1):24-5. PubMed ID: 19284015 [TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives. Modesto W; Bahamondes MV; Bahamondes L Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309 [TBL] [Abstract][Full Text] [Related]
8. Six- and twelve-month documented removal rates among women electing postpartum inpatient compared to delayed or interval contraceptive implant insertions after Medicaid payment reform. Crockett AH; Pickell LB; Heberlein EC; Billings DL; Mills B Contraception; 2017 Jan; 95(1):71-76. PubMed ID: 27400823 [TBL] [Abstract][Full Text] [Related]
9. Immediate postpartum etonogestrel implant: a contraception option with long-term continuation. Wilson S; Tennant C; Sammel MD; Schreiber C Contraception; 2014 Sep; 90(3):259-64. PubMed ID: 24993485 [TBL] [Abstract][Full Text] [Related]
10. Management of etonogestrel subdermal implant-related bleeding. Casey PM; Long ME; Drozdowicz LB; Marnach ML; Weaver AL J Reprod Med; 2014; 59(5-6):306-12. PubMed ID: 24937974 [TBL] [Abstract][Full Text] [Related]
11. Subdermal Contraceptive Implant Insertion Trends and Retention in Adolescents. Tyson N; Lopez M; Merchant M; Postlethwaite D J Pediatr Adolesc Gynecol; 2021 Jun; 34(3):348-354. PubMed ID: 33388444 [TBL] [Abstract][Full Text] [Related]
12. Influence of age on tolerability, safety and effectiveness of subdermal contraceptive implants. López Del Cerro E; Serrano Diana C; Castillo Cañadas AM; González Mirasol E; García Santos F; Gómez García MT; González de Merlo G J Obstet Gynaecol; 2018 Oct; 38(7):979-984. PubMed ID: 29553853 [TBL] [Abstract][Full Text] [Related]
13. Amenorrhea in adolescents using the etonogestrel contraceptive implant. Tsevat D; Mercier R; Bernheimer C; Lin S; Schwartz B Contraception; 2024 May; 133():110413. PubMed ID: 38401772 [TBL] [Abstract][Full Text] [Related]
15. Continuation of the etonogestrel implant in women undergoing immediate postabortion placement. Madden T; Eisenberg DL; Zhao Q; Buckel C; Secura GM; Peipert JF Obstet Gynecol; 2012 Nov; 120(5):1053-9. PubMed ID: 23090522 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Funk S; Miller MM; Mishell DR; Archer DF; Poindexter A; Schmidt J; Zampaglione E; Contraception; 2005 May; 71(5):319-26. PubMed ID: 15854630 [TBL] [Abstract][Full Text] [Related]
17. Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users. Lazorwitz A; Aquilante CL; Dindinger E; Harrison M; Sheeder J; Teal S Obstet Gynecol; 2019 Oct; 134(4):807-813. PubMed ID: 31503152 [TBL] [Abstract][Full Text] [Related]
18. A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system. Weisberg E; Bateson D; McGeechan K; Mohapatra L Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):5-14. PubMed ID: 24229367 [TBL] [Abstract][Full Text] [Related]
19. Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial. Hou MY; McNicholas C; Creinin MD Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):361-6. PubMed ID: 27419258 [TBL] [Abstract][Full Text] [Related]
20. Quality of life of women using the etonogestrel long-acting reversible contraceptive implant after abortion for unplanned pregnancy. Caruso S; Vitale SG; Fava V; Pasqua SD; Rapisarda AMC; Cianci S Eur J Contracept Reprod Health Care; 2020 Aug; 25(4):251-258. PubMed ID: 32436733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]